You are on page 1of 1

9/27/2017 Predicting progression in patients with Parkinson's disease - The Lancet Neurology

Home Journals Specialties The Lancet Clinic Global Health Multimedia Campaigns More Information for Submit a Paper

Login | Register | Claim Subscription | Subscribe

Online First Current Issue All Issues Multimedia About the Journal
All Content Search Advanced Search

Online First Next Article > Access this article on ScienceDirect

Comment
Article Options
Predicting progression in patients with Parkinson's disease PDF (39 KB)
Cornelis Blauwendraat, Sara Bandrs-Ciga, Andrew B Singleton
Published: 25 September 2017 Email Article
DOI: http://dx.doi.org/10.1016/S1474-4422(17)30331-9 Add to My Reading List
Article Info Export Citation
Create Citation Alert
Summary Full Text References Cited by in Scopus (0)
A major challenge to patients, clinicians, family members, and scientists is the unpredictable future
that accompanies a diagnosis of Parkinson's disease. When met with the question what does my Linked Articles
future hold? it is diicult to give predictions that are likely to be useful to the patient. Some
individuals will face features that rapidly and adversely aect their quality of life; others will ARTICLES
experience a prolonged and fairly benign course, initially well managed by drugs and lifestyle Large-scale identification of clinical and
changes. Variability between patients in core features of this multisystem diseaseeg, motor decline, genetic predictors of motor progression in
neuropsychiatric changes, mood disorders, dysautonomic signs, and fatigueis the rule. patients with newly diagnosed
Next
Parkinson's disease: a longitudinal cohort
To read this article in full you will need to make a payment study and validation Articles
Large-scale identification of
clinical and genetic
predictors of motor
Already registered? Please login. Payment Options progression in patients with
Popular Articles newly diagnosed Parkinson's
Login to existing account Purchase this article for $31.50 USD disease: a longitudinal
Forgot password? Online access for 24 hours Most Read Most Cited
cohort study and validation
PDF version can be downloaded as
your permanent record Most read in The Lancet Neurology within the
past 30 days.
Subscribe to The Lancet Neurology
Register Purchase a subscription to gain access to
Create a new account this and all other articles in this journal. GLOBAL HEALTH METRICS
Global, regional, and national burden of
Options include: neurological disorders during 1990
The Lancet Choice Personal online only subscription 2015: a systematic analysis for the
Access any 5 articles from The Lancet Global Burden of Disease Study 2015
family of journals Published: September 17, 2017
Full text and PDF access to 5 paywall Institutional Access Open Access
articles of your choice Visit ScienceDirect to see if you have
Valid for 365 days from date of access via your institution.
REVIEW
purchase Neurobehavioural eects of
Find out more about The Lancet Choice developmental toxicity
Already a print subscriber? Vol. 13, No. 3
Claim online access Published: March, 2014
Have a free trial code? EDITORIAL
Activate your free trial Pointing the way to primary prevention
of dementia
Vol. 16, No. 9
Published: September, 2017
REVIEW
Reversible cerebral vasoconstriction
syndrome
Vol. 11, No. 10
Published: October, 2012
EDITORIAL
http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(17)30331-9/fulltext Treating rare disorders: time to act on 1/2